Compare ICG & DRIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ICG | DRIO |
|---|---|---|
| Founded | 2017 | 2011 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 97.1M | 84.1M |
| IPO Year | 2023 | N/A |
| Metric | ICG | DRIO |
|---|---|---|
| Price | $1.51 | $10.02 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $7.50 | ★ $50.00 |
| AVG Volume (30 Days) | ★ 79.4K | 10.4K |
| Earning Date | 02-26-2026 | 03-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 94.43 | N/A |
| EPS | ★ 0.21 | N/A |
| Revenue | ★ $36,367,850.00 | $24,732,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $75.98 | $7.64 |
| P/E Ratio | $7.13 | ★ N/A |
| Revenue Growth | 6.53 | ★ 7.29 |
| 52 Week Low | $0.93 | $5.94 |
| 52 Week High | $4.20 | $17.74 |
| Indicator | ICG | DRIO |
|---|---|---|
| Relative Strength Index (RSI) | 40.16 | 50.22 |
| Support Level | $1.61 | $9.59 |
| Resistance Level | $1.79 | $11.77 |
| Average True Range (ATR) | 0.16 | 0.77 |
| MACD | -0.06 | -0.01 |
| Stochastic Oscillator | 29.33 | 52.48 |
Intchains Group Ltd provides integrated solutions consisting of high-performance ASIC chips and ancillary software and hardware for blockchain applications. Its ASIC chips are designed for several key blockchain algorithms including Blake2bsha3, sha512MD160, Cryptonight V4, Eaglesong, Blake2s and others. The company has built a proprietary technology platform named Xihe Platform, which allows the development of a wide range of ASIC chips with high efficiency and scalability. It designs its ASIC chips in-house, which enables it to leverage proprietary silicon data to deliver products reflecting the latest technological developments. Geographically, it operates in Mainland China, Hong Kong, and Other countries or regions.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.